Psychedelic Stock Goes Nuts
This biotech stock focused on psychedelics is seeking to disrupt the mental health market.
Click here for the full story

RGNX Insider Trading (REGENXBIO)

Insider Ownership Percentage: 14.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $7,621,212.21

REGENXBIO Insider Trading History Chart

REGENXBIO Share Price & Price History

$36.64
▼ -2.57 (-6.55%)
As of 03/5/2021 12:15 PM ET
Days: 30 | 90 | 365
Exploding CBD Market For Pampered Pets
The year’s top cannabis play is likely not a pot stock. It’s a seed-to-sale cannabis company that makes CBD from hemp. This company grows what it says is the world’s most CBD-rich hemp. Among its array of pure CBD products are those aimed at the health of American pets. It’s worth a look because that will soon be a $2 billion market.
We’ve Got A Soft Spot For Our Pets, Check It Out

REGENXBIO Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/25/2021Kenneth T MillsCEOSell6,500$44.74$290,810.00287,484  
1/14/2021Curran SimpsonInsiderSell13,312$50.01$665,733.1219,448  
1/14/2021Vittal VasistaCFOSell15,293$50.02$764,955.86124,985  
1/12/2021Vittal VasistaCFOSell4,200$50.01$210,042.00124,985  
1/11/2021Patrick J ChristmasInsiderSell10,122$49.08$496,787.7626,372  
1/8/2021Vittal VasistaCFOSell16,239$49.06$796,685.34134,426  
1/7/2021Curran SimpsonInsiderSell5,185$50.01$259,301.8522,933  
1/7/2021Kenneth T MillsCEOSell1,500$50.01$75,015.00283,484  
12/23/2020Kenneth T MillsCEOSell4,500$50.00$225,000.00245,500  
12/23/2020Vittal VasistaCFOSell21,124$50.01$1,056,411.24136,400  
12/16/2020Kenneth T MillsCEOSell15,000$45.00$675,000.00256,000  
12/10/2020Kenneth T MillsCEOSell4,500$40.00$180,000.00245,500  
12/10/2020Vittal VasistaCFOSell22,584$40.06$904,715.04172,440  
7/15/2020Vittal VasistaCFOSell14,950$40.10$599,495.00209,974  
5/11/2020Vittal VasistaCFOSell500$40.00$20,000.00213,715  
5/8/2020Vittal VasistaCFOSell7,000$40.18$281,260.00213,715  
4/23/2020Vittal VasistaCFOSell3,000$40.00$120,000.00223,215  
1/17/2020Curran SimpsonSVPSell5,922$50.00$296,100.0025,570  
1/17/2020Donald J Hayden JrDirectorSell3,200$50.01$160,032.003,200  
1/17/2020Vittal VasistaCFOSell2,394$50.00$119,700.00222,321  
1/14/2020Donald J Hayden JrDirectorSell30,000$45.60$1,368,000.0030,000  
1/8/2020Vittal VasistaCFOSell7,500$41.75$313,125.00232,215  
9/19/2019Kenneth T MillsCEOSell10,000$39.75$397,500.00251,000  
9/12/2019Patrick J ChristmasSVPSell5,486$42.00$230,412.008,058  
8/19/2019Kenneth T MillsInsiderSell15,000$37.55$563,250.00261,000  
7/19/2019Kenneth T MillsInsiderSell15,000$49.49$742,350.00261,000  
7/19/2019Patrick J ChristmasSVPSell5,000$50.03$250,150.003,058  
6/19/2019Kenneth T MillsInsiderSell15,000$52.54$788,100.00261,000  
6/18/2019Patrick J ChristmasSVPSell5,000$52.99$264,950.008,006  
5/28/2019Curran SimpsonSVPSell18,000$50.00$900,000.0057,500  
5/20/2019Kenneth T MillsInsiderSell15,000$42.99$644,850.00261,000  
4/22/2019Kenneth T MillsCEOSell15,000$50.44$756,600.00261,000  
4/18/2019Patrick J ChristmasSVPSell5,000$53.23$266,150.006,547  
4/15/2019Olivier DanosInsiderSell2,000$52.66$105,320.008,500  
3/21/2019Vittal VasistaCFOSell10,000$60.75$607,500.00230,915  
3/19/2019Kenneth T MillsCEOSell15,000$58.53$877,950.00261,000  
3/5/2019Vittal VasistaCFOSell3,068$60.01$184,110.68239,215  
2/25/2019Curran SimpsonSVPSell5,300$54.05$286,465.0044,800  
2/15/2019Kenneth T MillsCEOSell15,000$47.29$709,350.00261,000  
2/5/2019Curran SimpsonSVPSell43,832$50.08$2,195,106.5647,950  
1/15/2019Kenneth T MillsInsiderSell15,000$43.85$657,750.00204,140  
12/18/2018Patrick J ChristmasSVPSell5,000$47.54$237,700.007,669  
12/17/2018Kenneth T MillsInsiderSell15,000$46.73$700,950.00223,396  
12/17/2018Vittal VasistaCFOSell7,500$46.35$347,625.00125,683  
11/29/2018Luke M BesharDirectorSell12,784$65.00$830,960.0012,784  
11/27/2018Luke M BesharDirectorSell20,507$65.03$1,333,570.211,721  
11/26/2018Kenneth T MillsInsiderSell20,000$64.17$1,283,400.00259,620  
11/21/2018Kenneth T MillsInsiderSell15,000$61.44$921,600.00284,700  
11/20/2018Luke M BesharDirectorSell33,292$60.44$2,012,168.48  
11/19/2018Stephen YooInsiderSell20,414$59.53$1,215,245.42  
11/16/2018Curran SimpsonSVPSell32,882$63.76$2,096,556.32  
11/15/2018Vittal VasistaCFOSell7,500$60.29$452,175.00  
11/12/2018Kenneth T MillsInsiderSell20,000$63.11$1,262,200.00  
11/7/2018Patrick J ChristmasSVPSell15,000$72.06$1,080,900.002,669  
11/5/2018Kenneth T MillsInsiderSell20,000$68.25$1,365,000.00322,500  
11/2/2018Vittal VasistaCFOSell73,418$70.20$5,153,943.60147,242  
10/29/2018Stephen YooInsiderSell20,414$62.37$1,273,221.1820,414  
10/18/2018Patrick J ChristmasSVPSell5,000$61.78$308,900.0022,669  
10/16/2018Curran SimpsonSVPSell62,309$60.85$3,791,502.6586,017  
10/16/2018Stephen YooInsiderSell20,414$60.28$1,230,555.9210,000  
10/15/2018Kenneth T MillsCEOSell7,510$59.35$445,718.50331,710  
10/15/2018Vittal VasistaCFOSell7,500$59.37$445,275.00142,283  
10/8/2018Olivier DanosInsiderSell20,000$63.80$1,276,000.0020,000  
9/17/2018Kenneth T MillsInsiderSell7,510$74.91$562,574.10339,505  
9/17/2018Vittal VasistaCFOSell7,500$74.86$561,450.00120,722  
8/27/2018Kenneth T MillsInsiderSell7,510$66.46$499,114.60348,530  
8/20/2018Patrick J ChristmasSVPSell5,000$65.96$329,800.0022,669  
8/15/2018Vittal VasistaCFOSell7,500$65.43$490,725.00123,584  
7/16/2018Vittal VasistaCFOSell7,500$75.54$566,550.00134,655  
6/20/2018Kenneth T MillsInsiderSell5,000$66.20$331,000.00208,330  
6/18/2018Patrick J ChristmasSVPSell5,000$56.78$283,900.0021,141  
6/15/2018Vittal VasistaCFOSell7,500$56.61$424,575.00  
6/5/2018Donald J Hayden JrDirectorSell15,000$55.01$825,150.00100  
6/1/2018Donald J Hayden JrDirectorSell100$55.00$5,500.00100  
5/21/2018Kenneth T MillsInsiderSell10,000$47.05$470,500.00  
5/15/2018Donald J Hayden JrDirectorSell15,000$50.05$750,750.00  
5/15/2018Vittal VasistaCFOSell7,500$50.10$375,750.00  
4/20/2018Kenneth T MillsInsiderSell10,000$39.52$395,200.00219,430  
4/16/2018Vittal VasistaCFOSell5,000$37.56$187,800.00154,434  
4/11/2018Patrick J ChristmasSVPSell10,000$39.00$390,000.0011,141  
4/9/2018Patrick J ChristmasSVPSell10,000$34.00$340,000.0011,141  
3/26/2018Vittal VasistaCFOSell5,000$30.00$150,000.00157,283  
3/20/2018Kenneth T MillsInsiderSell10,000$29.55$295,500.00228,530  
3/13/2018Curran SimpsonSVPSell25,000$33.00$825,000.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for REGENXBIO (NASDAQ:RGNX)

75.23% of REGENXBIO stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

REGENXBIO Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/4/2021Hudson Bay Capital Management LP40,000$1.81M0.0%-84.8%0.107%
3/2/2021Norges Bank334,857$15.19M0.0%N/A0.895%
2/25/2021Dimensional Fund Advisors LP691,444$31.37M0.0%+0.9%1.848%
2/24/2021Virtu Financial LLC9,698$0.44M0.0%N/A0.026%
2/24/2021Bank Julius Baer & Co. Ltd Zurich19,180$0.87M0.0%+62.4%0.051%
2/23/2021Principal Financial Group Inc.222,202$10.08M0.0%+0.5%0.594%
2/19/2021JPMorgan Chase & Co.2,601,366$118M0.0%+31.0%6.954%
2/19/2021AtonRa Partners47,563$2.16M1.1%N/A0.127%
2/17/2021Voloridge Investment Management LLC12,224$0.55M0.0%N/A0.033%
2/17/2021IHT Wealth Management LLC12,442$0.56M0.0%-9.9%0.033%
2/16/2021Squarepoint Ops LLC17,239$0.78M0.0%-62.2%0.046%
2/16/2021Morgan Stanley182,179$8.26M0.0%-41.6%0.487%
2/16/2021Nuveen Asset Management LLC129,097$5.86M0.0%-1.9%0.345%
2/16/2021Guggenheim Capital LLC11,576$0.53M0.0%N/A0.031%
2/16/2021Price T Rowe Associates Inc. MD288,836$13.10M0.0%-3.1%0.772%
2/16/2021Virginia Retirement Systems ET AL5,200$0.24M0.0%N/A0.014%
2/16/2021Engineers Gate Manager LP6,290$0.29M0.0%-49.4%0.017%
2/16/2021Gyon Technologies Capital Management LP7,234$0.33M0.1%N/A0.019%
2/16/2021Charles Schwab Investment Management Inc.206,494$9.37M0.0%+1.3%0.552%
2/13/2021American International Group Inc.22,551$1.02M0.0%-2.5%0.060%
2/12/2021Vantage Consulting Group Inc1,652$75K0.0%N/A0.004%
2/12/2021Penserra Capital Management LLC860$39K0.0%+168.8%0.002%
2/12/2021Amalgamated Bank5,585$0.25M0.0%N/A0.015%
2/12/2021The Manufacturers Life Insurance Company 20,695$0.94M0.0%+3.2%0.055%
2/12/2021Credit Suisse AG59,737$2.71M0.0%-88.7%0.160%
2/12/2021Vontobel Holding Ltd.10,000$0.45M0.0%N/A0.027%
2/12/2021Virtus ETF Advisers LLC7,339$0.33M0.1%-16.2%0.020%
2/11/2021Lazard Asset Management LLC1,759$79K0.0%+25.4%0.005%
2/11/2021P.A.W. Capital Corp40,000$1.81M1.6%-46.7%0.107%
2/11/2021WS Management Lllp257,929$11.70M1.2%-41.0%0.690%
2/11/2021Northern Trust Corp390,732$17.72M0.0%-2.1%1.045%
2/11/2021Barclays PLC40,554$1.84M0.0%-43.5%0.108%
2/11/2021Citigroup Inc.90,511$4.11M0.0%-54.3%0.242%
2/11/2021Handelsbanken Fonder AB7,100$0.32M0.0%N/A0.019%
2/11/2021Frazier Management LLC341,954$15.51M1.2%+96.3%0.914%
2/11/2021Veriti Management LLC1,327$60K0.0%N/A0.004%
2/10/2021Rhumbline Advisers71,579$3.25M0.0%-5.8%0.191%
2/10/2021Panagora Asset Management Inc.2,024$92K0.0%-96.5%0.005%
2/10/2021Korea Investment CORP489,971$22.23M0.1%+9.9%1.310%
2/9/2021Wells Fargo & Company MN42,350$1.92M0.0%+20.5%0.113%
2/9/2021ClariVest Asset Management LLC10,887$0.49M0.0%-57.7%0.029%
2/9/2021Bank of New York Mellon Corp314,731$14.28M0.0%-2.5%0.841%
2/9/2021Quantitative Systematic Strategies LLC4,540$0.21M0.0%N/A0.012%
2/9/2021Oregon Public Employees Retirement Fund12,070$0.55M0.0%-6.9%0.032%
2/9/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.6,607$0.30M0.0%+32.0%0.018%
2/9/2021ProShare Advisors LLC13,888$0.63M0.0%+29.4%0.037%
2/8/2021Principal Financial Group Inc.222,202$10.08M0.0%+0.5%0.594%
2/8/2021State Board of Administration of Florida Retirement System18,161$0.82M0.0%-3.4%0.049%
2/8/2021New York State Common Retirement Fund30,400$1.38M0.0%-7.0%0.081%
2/8/2021Russell Investments Group Ltd.31,073$1.41M0.0%+317.9%0.083%
2/5/2021BlackRock Inc.5,433,372$246.46M0.0%-3.9%14.525%
2/5/2021Aperio Group LLC9,938$0.45M0.0%N/A0.027%
2/5/2021SG Americas Securities LLC2,900$0.13M0.0%-96.4%0.008%
2/4/2021Texas Permanent School Fund24,029$1.09M0.0%-13.9%0.064%
2/4/2021Prentiss Smith & Co. Inc.11,776$0.53M0.3%-5.0%0.031%
2/4/2021State of Wisconsin Investment Board49,000$2.22M0.0%-11.1%0.131%
2/3/2021State of New Jersey Common Pension Fund D77,943$3.54M0.0%N/A0.208%
2/2/2021California Public Employees Retirement System69,400$3.15M0.0%-2.1%0.186%
1/29/2021Newman Dignan & Sheerar Inc.4,522$0.21M0.0%N/A0.012%
1/28/2021Arizona State Retirement System9,191$0.42M0.0%-3.8%0.025%
1/28/2021Zurcher Kantonalbank Zurich Cantonalbank4,113$0.19M0.0%+37.1%0.011%
1/27/2021Exane Derivatives3,958$0.18M0.1%+25.9%0.011%
1/25/2021XTX Markets LLC4,427$0.20M0.4%N/A0.012%
1/25/2021Nisa Investment Advisors LLC4,575$0.21M0.0%+68.5%0.012%
1/21/2021Altfest L J & Co. Inc.6,172$0.28M0.1%N/A0.016%
1/21/2021Cutler Group LP3,400$0.15M0.0%N/A0.009%
1/20/2021Pacer Advisors Inc.1,734$79K0.0%-26.1%0.005%
1/14/2021Crossmark Global Holdings Inc.8,890$0.40M0.0%N/A0.024%
1/8/2021State of Alaska Department of Revenue23,286$1.06M0.0%-16.3%0.062%
11/19/2020IHT Wealth Management LLC13,812$0.38M0.0%+23.4%0.037%
11/18/2020Great West Life Assurance Co. Can33,312$0.92M0.0%-13.7%0.089%
11/17/2020Twinbeech Capital LP9,074$0.25M0.1%N/A0.024%
11/17/2020California State Teachers Retirement System51,457$1.42M0.0%+1.1%0.138%
11/16/2020Cubist Systematic Strategies LLC20,423$0.56M0.0%+109.7%0.055%
11/16/2020AQR Capital Management LLC14,794$0.41M0.0%+56.0%0.040%
11/16/2020Squarepoint Ops LLC45,581$1.25M0.0%+88.7%0.122%
11/16/2020Advisors Asset Management Inc.4,511$0.12M0.0%+86.3%0.012%
11/13/2020Public Sector Pension Investment Board66,122$1.82M0.0%-6.5%0.177%
11/13/2020Morgan Stanley311,852$8.58M0.0%+65.1%0.834%
11/13/2020ProShare Advisors LLC10,730$0.30M0.0%-3.4%0.029%
11/13/2020Charles Schwab Investment Management Inc.203,869$5.61M0.0%-5.5%0.545%
11/13/2020Virtus ETF Advisers LLC8,759$0.24M0.1%-12.0%0.023%
11/13/2020Sofinnova Investments Inc.59,507$1.64M0.1%N/A0.159%
11/13/2020Great West Life Assurance Co. Can33,312$0.90M0.0%-13.7%0.089%
11/13/2020Botty Investors LLC298,404$8.21M2.6%-0.8%0.798%
11/12/2020JPMorgan Chase & Co.1,986,112$55.43M0.0%+3.7%5.309%
11/12/2020Essex Investment Management Co. LLC36,310$1M0.1%+140.3%0.097%
11/11/2020Thrivent Financial for Lutherans24,765$0.68M0.0%-6.5%0.066%
11/10/2020State Street Corp2,143,897$59M0.0%-4.5%5.731%
11/10/2020Bank Julius Baer & Co. Ltd Zurich11,810$0.28M0.0%+784.0%0.032%
11/9/2020P.A.W. Capital Corp75,000$2.06M2.2%+7.1%0.200%
11/9/2020SG Americas Securities LLC81,584$2.25M0.0%+748.9%0.218%
11/9/2020The Manufacturers Life Insurance Company20,053$0.55M0.0%-1.7%0.054%
11/9/2020ClariVest Asset Management LLC25,747$0.71M0.0%-4.3%0.069%
11/9/2020Swiss National Bank71,700$1.97M0.0%+1.7%0.192%
11/9/2020State Board of Administration of Florida Retirement System18,801$0.52M0.0%+3.5%0.050%
11/6/2020GAM Holding AG135,475$3.73M0.2%+28.7%0.363%
11/6/2020BlackRock Inc.5,656,642$155.67M0.0%+2.0%15.151%
11/6/2020Principal Financial Group Inc.221,139$6.09M0.0%-11.5%0.592%
11/6/2020Aigen Investment Management LP45,802$1.26M0.2%+412.4%0.123%
Data available starting January 2016

See Full Table
REGENXBIO logo
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II; RGX-111, which is in Phase I clinical trial for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II disease; and RGX-501, which is in Phase I/II clinical trials to treat homozygous familial hypercholesterolemia. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop vectorized antibodies for the treatment of neurodegenerative diseases. The company was formerly known as ReGenX Biosciences, LLC and changed its name to REGENXBIO Inc. in September 2014. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.
Read More

Today's Range

Now: $36.64
$36.60
$39.27

50 Day Range

MA: $44.36
$39.98
$49.95

52 Week Range

Now: $36.64
$20.03
$50.26

Volume

17,282 shs

Average Volume

521,035 shs

Market Capitalization

$1.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

Who are the company insiders with the largest holdings of REGENXBIO?

REGENXBIO's top insider shareholders include:
  1. Kenneth T Mills (CEO)
  2. Kenneth T Mills (Insider)
  3. Vittal Vasista (CFO)
  4. Curran Simpson (SVP)
  5. Donald J Hayden Jr (Director)
  6. Patrick J Christmas (Insider)
  7. Curran Simpson (Insider)
  8. Olivier Danos (Insider)
  9. Patrick J Christmas (SVP)

Who are the major institutional investors of REGENXBIO?

REGENXBIO's top institutional investors include:
  1. BlackRock Inc. — 14.52%
  2. JPMorgan Chase & Co. — 6.95%
  3. Dimensional Fund Advisors LP — 1.85%
  4. Korea Investment CORP — 1.31%
  5. Northern Trust Corp — 1.04%
  6. Frazier Management LLC — 0.91%

Which institutional investors are selling REGENXBIO stock?

In the previous quarter, RGNX stock was sold by these institutional investors:
  1. Credit Suisse AG
  2. BlackRock Inc.
  3. Hudson Bay Capital Management LP
  4. WS Management Lllp
  5. Morgan Stanley
  6. Citigroup Inc.
  7. SG Americas Securities LLC
  8. Panagora Asset Management Inc.
In the previous year, company insiders that have sold REGENXBIO company stock include:
  1. Kenneth T Mills (CEO)
  2. Kenneth T Mills (Insider)
  3. Vittal Vasista (CFO)
  4. Curran Simpson (SVP)

Which institutional investors are buying REGENXBIO stock?

Within the previous quarter, RGNX stock was bought by institutional investors including:
  1. JPMorgan Chase & Co.
  2. Norges Bank
  3. Frazier Management LLC
  4. State of New Jersey Common Pension Fund D
  5. AtonRa Partners
  6. Korea Investment CORP
  7. Russell Investments Group Ltd.
  8. Voloridge Investment Management LLC
Psychedelic Stock Goes Nuts
This biotech stock focused on psychedelics is seeking to disrupt the mental health market.
Click here for the full story